Bibliographic Details
| Title: |
LC-MS analysis and antioxidant, antibacterial, and antidiabetic activity of Jumli Marshi rice from Nepal: An in vitro and in silico investigation to validate their potential as a functional food. |
| Authors: |
Yadav, Ram Kishor1 (AUTHOR), Bhandari, Rekha1 (AUTHOR), Babu P C, Harish2 (AUTHOR), Jha, Prabhat Kumar3 (AUTHOR), Pandey, Bipindra3 (AUTHOR) bipindra.p101@gmail.com, KC, Sindhu1 (AUTHOR), Upadhaya, Siddha Raj4 (AUTHOR), Panta, Sushil1 (AUTHOR), Shyaula, Sajan Lal5 (AUTHOR), Joshi, Khem Raj1 (AUTHOR) |
| Source: |
PLoS ONE. 3/10/2025, Vol. 20 Issue 3, p1-33. 33p. |
| Subject Terms: |
*LIQUID chromatography-mass spectrometry, *MOLECULAR docking, *PHENOLIC acids, *FUNCTIONAL foods, *VITAMIN C, *CHLOROGENIC acid |
| Abstract: |
Jumli Marshi (J. Marshi), a native rice cultivar in Nepal, is gaining popularity owing to its health benefits for obesity, hypertension, and diabetes. However, scientific evidence verifying its therapeutic potential is lacking until November 2024. Therefore, we aimed to characterize the phytoconstituents and evaluate the antioxidant, antibacterial, and antidiabetic properties of J. Marshi, along with its ADME toxicity profile, using both in vitro and in silico approaches. Liquid chromatography-mass spectrometry analysis of a 70% methanol extract from J. Marshi identified ten plant-based compounds, including phenolic acids, flavonoids, and γ-oryzanol. The extract exhibited significant antioxidant properties, neutralizing DPPH free radicals with a fifty-percentage inhibitory concentration (IC50) of 42.65 ± 3.9 µg/mL, compared to ascorbic acid's IC50 of 4.12 ± 0.7 µg/mL. It also showed antibacterial activity against Staphylococcus aureus, with a zone of inhibition (ZOI) ranging from 7 to 11 mm and a minimum inhibitory concentration (MIC) of 1.56 mg/mL, compared to standard antibiotics meropenem (ZOI: 24 ± 1.6 mm; MIC: 1.56 mg/mL). The enzymatic assay demonstrated that the J. Marshi extract inhibits fifty percent of enzyme activity at a concentration (EC50) of > 1000 µg/mL for α-amylase and 250 ± 2.5 µg/mL for α-glucosidase, in contrast to the standard acarbose, exhibiting an EC50 of 35.5 ± 1.5 µg/mL for α-amylase and 189.5 ± 1.9 µg/mL for α-glucosidase. In silico docking studies revealed strong interactions of rice phytoconstituents with target protein catalytic residues, particularly gamma-oryzanol for α-amylase (−10.0 kcal/mol) and chlorogenic acid for α-glucosidase (−7.7 kcal/mol), compared to acarbose (−6.9 to −7.1 kcal/mol). ADME toxicity analysis suggested that tricin and gamma-oryzanol had the best drug-likeness and safety profiles. To our knowledge, this is the first study to reveal the presence of bioactive phenolic acids and flavonoids. Furthermore, it offers scientific evidence supporting significant antioxidant and α-glucosidase-inhibitory properties, confirming the potential applications of J. Marshi rice as a functional food used for the management of diabetes. [ABSTRACT FROM AUTHOR] |
|
Copyright of PLoS ONE is the property of Public Library of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
